TECHWIRE 30
(CIX: WRAL30)  1,148.07  up arrow+0.53  (0.05 %)  Updated: 12:50 PM EST, Nov 28 2014
(NQ: Apple)  118.65  down arrow-0.35  (-0.29 %)  Updated: 12:51 PM EST, Nov 28 2014
(NY: QUINTILES)  57.68  down arrow-0.28  (-0.48 %)  Updated: 12:50 PM EST, Nov 28 2014
(OP: BASF SE)  90.64  down arrow-3.57  (-3.78 %)  Updated: 12:50 PM EST, Nov 28 2014
(NQ: BioCryst)  10.82  down arrow-0.56  (-4.92 %)  Updated: 12:50 PM EST, Nov 28 2014
(NQ: BioDelivery)  15.32  down arrow-0.48  (-3.04 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: CEMP)  14.45  down arrow-0.09  (-0.62 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: Cisco Systems)  27.60  up arrow+0.18  (0.64 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: Cree)  36.25  down arrow-0.49  (-1.33 %)  Updated: 12:50 PM EST, Nov 28 2014
(NQ: DARA)  0.80  up arrow+0.02  (2.42 %)  Updated: 12:45 PM EST, Nov 28 2014
(NY: EMC CORPORATION)  30.33  up arrow+0.29  (0.97 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: Extreme Networks)  3.61  down arrow-0.02  (-0.55 %)  Updated: 12:50 PM EST, Nov 28 2014
(NQ: FB)  77.64  up arrow+0.02  (0.03 %)  Updated: 12:51 PM EST, Nov 28 2014
(NY: GLAXOSMITHKLINE)  46.46  down arrow-0.06  (-0.13 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: GOOG)  541.38  up arrow+1.01  (0.19 %)  Updated: 12:51 PM EST, Nov 28 2014
(NY: IBM)  162.18  up arrow+0.23  (0.14 %)  Updated: 12:50 PM EST, Nov 28 2014
(NY: LH)  104.50  up arrow+2.35  (2.3 %)  Updated: 12:51 PM EST, Nov 28 2014
(OP: Lenovo Group)  27.97  up arrow+0.08  (0.29 %)  Updated: 12:40 PM EST, Nov 28 2014
(NY: MRK)  60.34  up arrow+0.59  (0.99 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: Microsoft Corp)  47.77  up arrow+0.02  (0.03 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: NTAP)  42.54  down arrow-0.16  (-0.37 %)  Updated: 12:51 PM EST, Nov 28 2014
(NY: NOVARTIS AG)  96.57  up arrow+1.01  (1.06 %)  Updated: 12:50 PM EST, Nov 28 2014
(OP: Novozymes A/S)  44.16  down arrow-1.66  (-3.62 %)  Updated: 12:44 PM EST, Nov 28 2014
(NY: PFIZER)  31.10    (0 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: Pozen)  8.96  down arrow-0.04  (-0.44 %)  Updated: 12:50 PM EST, Nov 28 2014
(NY: RED HAT)  62.11  up arrow+0.01  (0.02 %)  Updated: 12:50 PM EST, Nov 28 2014
(NQ: BBRY)  10.39  down arrow-0.1  (-0.91 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: Salix)  102.71  down arrow-0.54  (-0.52 %)  Updated: 12:51 PM EST, Nov 28 2014
(NQ: SQI)  14.86  down arrow-0.39  (-2.56 %)  Updated: 12:50 PM EST, Nov 28 2014

Posts tagged “Quintiles”

April 16, 2002

Premium Lock Quintiles, Orion Sign Letter of Intent To Form Drug Development

Venture to develop portfolio of selected products currently in Phases I through III from Orion's pharmaceutical division.

Tags: Quintiles
April 15, 2002

Premium Lock Hot off the Wire: RIAA Deadline; Saffron Deal; NFL Draft Goes Wireless; SpringBoard Hire; More ...

Rural Internet extends project deadline; big deal for Saffron; SpringBoard hires manager; Quintiles forms new venture; Air2Web to work with NFL; TrianglePR grows; SlickEdit's new release; nTouch expands.

April 8, 2002

Premium Lock Quintiles Chairman To Lead New CRO Group

Five companies, including PPD, form lobbying organization in Washington, DC.

Tags: Quintiles
April 5, 2002

Premium Lock Hot Off the Wire: News from D&T 'Fast 50', Summus, BellSouth, Digital Envoy ...

D&T seeking nominations for annual "Fast 50"; Summus offers new port capability; BellSouth reaches out to hearing and voice impaired; Digital Envoy to work with Verisign; more ...

March 18, 2002

Premium Lock Magellan Merges With Cardinal; Quintiles Forming New Unit

'Together our operations can provide a full spectrum of services, from pre-clinical to commercial manufacturing,' Magellan co-founder says. <b> Other news: </b> Quintiles exec to head joint venture; Salix gets $57 million in stock sale.

Tags: Quintiles
February 3, 2002

Premium Lock Quintiles Hopes Deal with Kos Pharmaceuticals Will Continue Upward-Moving Trend

RTP firm trains 150-member sales force to help boost sales of two anti-cholesterol drugs, including one just recently approved by FDA. Quintiles will get a commission.

January 31, 2002

Premium Lock Wilmington's PPD Acquires Two Companies, Regains HIV Targets; Stock Jumps 15 Percent

PPD Inc., a contract research organization, acquires two specialized labs and regains rights to targets for anti-AIDs drugs. Earnings up 27 percent. Also: Pozen begins final trial on migraine drug; aaiPharma sets record; Quintiles makes deal.

Tags: PPD, Quintiles
January 25, 2002

Premium Lock Venture Capitalists Still Running Scared, Mumma Tells Crowd at CED Conference

Intersouth Partner tells entrepreneurs "to assume this will never change." VCs are "chicken" due to stock market woes and low public company values.

January 24, 2002

Premium Lock CED's Money & Markets Event Could Indicate Ending to Venture Freeze

More than 500 people are expected at the Money & Markets 2002 Conference to discuss financial issues of importance to early and mid-stage technology firms.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll